Ticker Scorecard - LYEL Basics Company: Lyell Immunopharma, Inc. IPO Date: June 17, 2021 Sector: Healthcare Industry: Biotech Market Cap: $204.72M Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 4.13% Avg Daily Range (30 D): $0.02 | 3.08% Avg Daily Range (90 D): $0.04 | 4.39% Institutional Daily Volume Avg Daily Volume: .76M Avg Daily Volume (30 D): .95M Avg Daily Volume (90 D): 1.13M Trade Size Avg Trade Size (Sh.): 125 Avg Trade Size (Sh.) (30 D): 330 Avg Trade Size (Sh.) (90 D): 272 Institutional Trades Total Inst.Trades: 337 Avg Inst. Trade: $1.97M Avg Inst. Trade (30 D): $1.86M Avg Inst. Trade (90 D): $1.39M Avg Inst. Trade Volume: .41M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.29M Avg Closing Trade (30 D): $.66M Avg Closing Trade (90 D): $1.26M Avg Closing Volume: 489.5K     News Oct 24, 2024 @ 8:00 PM Lyell Immunopharma to Acquire ImmPACT Bio and Prio... Source: Globe Newswire Oct 4, 2024 @ 1:00 PM Lyell Immunopharma Announces the Acceptance Abstra... Source: N/A Jul 8, 2024 @ 5:02 PM Advanced Melanoma Clinical Trial Pipeline Analysis... Source: Delveinsight Jun 26, 2024 @ 11:00 AM Lyell Immunopharma Reports Dose-dependent Clinical... Source: Lyell Immunopharma, Inc Jun 3, 2024 @ 8:05 PM Lyell Immunopharma to Participate in the Goldman S... Source: Lyell Immunopharma, Inc Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.79 $-.17 $-.18 Diluted EPS $-.79 $-.17 $-.18 Revenue $ .06M $ .03M $ .01M Gross Profit $ $ $ Net Income / Loss $ -203.99M $ -44.58M $ -45.81M Operating Income / Loss $ -217.12M $ -50.51M $ -51.53M Cost of Revenue $ $ $ Net Cash Flow $ -185.91M $ -33.12M $ 7.78M PE Ratio